Patents by Inventor Rolf Gunther

Rolf Gunther has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Publication number: 20230251242
    Abstract: The disclosure concerns a method and a device for enriching cells, cell fragments and molecules from whole blood for a specific detection of at least one population of cells, cell fragments or molecules contained therein. The task was to detect a broad spectrum of target objects including their molecules simply, quickly and yet sensitively and specifically from whole blood. According to the disclosure, not the target objects themselves, but matrix objects are specifically enriched, but target objects are specifically analyzed and thus a specific and sensitive detection of target objects is achieved.
    Type: Application
    Filed: March 17, 2023
    Publication date: August 10, 2023
    Inventors: Rolf GÜNTHER, Tobias PÖHLMANN, Heinrich Maria SCHULTE
  • Patent number: 11629374
    Abstract: The disclosure concerns a method and a device for enriching cells, cell fragments and molecules from whole blood for a specific detection of at least one population of cells, cell fragments or molecules contained therein. The task was to detect a broad spectrum of target objects including their molecules simply, quickly and yet sensitively and specifically from whole blood. According to the disclosure, not the target objects themselves, but matrix objects are specifically enriched, but target objects are specifically analyzed and thus a specific and sensitive detection of target objects is achieved.
    Type: Grant
    Filed: October 4, 2019
    Date of Patent: April 18, 2023
    Inventors: Rolf Günther, Tobias Pöhlmann, Heinrich Maria Schulte
  • Publication number: 20200032318
    Abstract: The disclosure concerns a method and a device for enriching cells, cell fragments and molecules from whole blood for a specific detection of at least one population of cells, cell fragments or molecules contained therein. The task was to detect a broad spectrum of target objects including their molecules simply, quickly and yet sensitively and specifically from whole blood. According to the disclosure, not the target objects themselves, but matrix objects are specifically enriched, but target objects are specifically analyzed and thus a specific and sensitive detection of target objects is achieved.
    Type: Application
    Filed: October 4, 2019
    Publication date: January 30, 2020
    Inventors: Rolf GÜNTHER, Tobias PÖHLMANN, Heinrich Maria SCHULTE
  • Patent number: 8246651
    Abstract: The present invention provides a method of capturing thrombi in a blood vessel, which includes delivering a removable filter in a collapsed state within the blood vessel and deploying the filter to an expanded state within the blood vessel. The filter includes a plurality of primary struts and a plurality of secondary struts emanating from a hub and extending arcuately along a longitudinal axis and linearly radially. Each primary strut has an arcuate segment including first and second curved portions. Each secondary strut includes first and second arcs. The primary struts terminate with an anchoring hook. Each primary strut crosses another primary strut along the longitudinal axis in the collapsed state such that the arcuate segments occupy a first diameter and the anchoring hooks occupy a second diameter, the first diameter being greater than the second diameter for filter retrieval or delivery.
    Type: Grant
    Filed: March 4, 2010
    Date of Patent: August 21, 2012
    Assignee: Cook Medical Technologies LLC
    Inventors: Per Hendriksen, Allan G. Hemmingsen, Arne Molgaard-Nielsen, Thomas A. Osborne, Rolf Gunther
  • Patent number: 8105349
    Abstract: A removable filter having a collapsed state and an expanded state for capturing thrombi in a blood vessel is disclosed. The filter comprises a plurality of primary struts and a plurality of secondary struts. Each primary strut in the expanded state extends from a primary strut first end to an anchoring hook. Each primary strut extends arcuately along a longitudinal axis and linearly radially. The plurality of primary strut first ends are attached together along the longitudinal axis. Each secondary strut in the expanded state extends from a secondary strut first end to a free end. Each secondary strut extends arcuately along the longitudinal axis and linearly radially. The plurality of secondary struts are attached together along the longitudinal axis. The plurality of secondary struts centralize the filter in the expanded state in the blood vessel.
    Type: Grant
    Filed: April 18, 2005
    Date of Patent: January 31, 2012
    Assignee: Cook Medical Technologies LLC
    Inventors: Per Hendriksen, Allan G. Hemmingsen, Arne Molgaard-Nielsen, Thomas A. Osborne, Rolf Gunther
  • Publication number: 20110286966
    Abstract: Modified endogenous human interferon-gamma (hIFN-?), biologically inactive but preserving binding affinity to the hIFN-? receptor, has applicability in the treatment of autoimmune diseases, especially multiple sclerosis.
    Type: Application
    Filed: February 28, 2011
    Publication date: November 24, 2011
    Inventors: Ivan Ivanov, Rumen Tsanev, Genoveva Nacheva, Hans-Guenther Grigoleit, Rolf Gunther
  • Publication number: 20110218325
    Abstract: Inactivated protein derivatives of the hIFN-? that preserve affinity to the hIFN-? receptor are useful in the treatment of autoimmune diseases, especially multiple sclerosis.
    Type: Application
    Filed: February 28, 2011
    Publication date: September 8, 2011
    Inventors: Ivan Ivanov, Rumen Tsaney, Genoveva Nacheva, Hans-Guenther Grigoleit, Rolf Gunther
  • Patent number: 7973133
    Abstract: The invention relates to an inhibitor of endogenous human interferon-gamma (hIFN-ϝ) in autoimmune diseases, especially in multiple sclerosis. More precisely, the invention relates to inactivated protein derivatives of the hIFN-ϝ with preserved affinity to the hIFN-ϝ receptor. The derivatives represent genetically modified variants of hIFN-ϝ where the C-terminal part of the molecule is either deleted or replaced with a polypeptide sequence of another human protein and a recombinant hIFN-ϝ inactivated by physical or chemical methods.
    Type: Grant
    Filed: October 5, 2005
    Date of Patent: July 5, 2011
    Inventors: Ivan Ivanov, Rumen Tsanev, Genoveva Nacheva, Hans-Guenther Grigoleit, Rolf Gunther
  • Publication number: 20100160956
    Abstract: The present invention provides a method of capturing thrombi in a blood vessel, which includes delivering a removable filter in a collapsed state within the blood vessel and deploying the filter to an expanded state within the blood vessel. The filter includes a plurality of primary struts and a plurality of secondary struts emanating from a hub and extending arcuately along a longitudinal axis and linearly radially. Each primary strut has an arcuate segment including first and second curved portions. Each secondary strut includes first and second arcs. The primary struts terminate with an anchoring hook. Each primary strut crosses another primary strut along the longitudinal axis in the collapsed state such that the arcuate segments occupy a first diameter and the anchoring hooks occupy a second diameter, the first diameter being greater than the second diameter for filter retrieval or delivery.
    Type: Application
    Filed: March 4, 2010
    Publication date: June 24, 2010
    Applicants: Cook Incorporated, William Cook Europe Aps
    Inventors: Per Hendriksen, Allan G. Hemmingsen, Arne Molgaard-Nielsen, Thomas A. Osborne, Rolf Gunther
  • Publication number: 20100158865
    Abstract: The invention relates to an inhibitor of endogenous human interferon-gamma (hIFN-ϝ) in autoimmune diseases, especially in multiple sclerosis. More precisely, the invention relates to inactivated protein derivatives of the hIFN-ϝ with preserved affinity to the hIFN-ϝ receptor. The derivatives represent genetically modified variants of hIFN-ϝ, where the C-terminal part of the molecule is either deleted or replaced with a polypeptide sequence of another human protein and a recombinant hIFN-ϝ, inactivated by physical or chemical methods.
    Type: Application
    Filed: January 20, 2010
    Publication date: June 24, 2010
    Inventors: Ivan Ivanov, Rumen Tsanev, Genoveva Nacheva, Hans-Guenther Grigoleit, Rolf Gunther
  • Patent number: 7699867
    Abstract: The present invention provides a removable vena cava filter for capturing thrombi in a blood vessel. The filter comprises a plurality of primary struts having first ends attached together along a longitudinal axis. Each primary strut has an arcuate segment extending from the first end to an anchoring hook. The primary struts are configured to move between an expanded state for engaging the anchoring hooks with the blood vessel and a collapsed state for filter retrieval or delivery. Each primary strut are configured to cross another primary strut along the longitudinal axis in the collapsed state such that the arcuate segments occupy a first diameter greater than a second diameter occupied by the anchoring hooks in the collapsed state for filter retrieval or delivery.
    Type: Grant
    Filed: April 18, 2005
    Date of Patent: April 20, 2010
    Assignees: Cook Incorporated, William Cook Europe APS
    Inventors: Per Hendriksen, Allan G. Hemmingsen, Arne Molgaard-Nielsen, Thomas A. Osborne, Rolf Gunther
  • Patent number: 7625390
    Abstract: The present invention provides a removable vena cava filter for capturing thrombi in a blood vessel. The filter comprises a plurality of primary struts having first ends attached together along a longitudinal axis. Each primary strut includes an arcuate segment having a first tensile strength. The arcuate segment extends from the first end to an anchoring hook. The anchoring hook is integral with the arcuate segment and having the first thickness and first tensile strength. The filter further comprises a plurality of secondary struts freely spaced between the primary struts and having connected ends attached together along the longitudinal axis. Each secondary strut freely extends from the connected end to a free end avoiding contact with other secondary struts and primary struts. Each secondary strut has a second tensile strength.
    Type: Grant
    Filed: April 18, 2005
    Date of Patent: December 1, 2009
    Assignee: Cook Incorporated
    Inventors: Per Hendriksen, Allan G. Hemmingsen, Arne Molgaard-Nielsen, Thomas A. Osborne, Rolf Gunther
  • Publication number: 20090208452
    Abstract: The invention relates to an inhibitor of endogenous human interferon-gamma (hIFN-ϝ) in autoimmune diseases, especially in multiple sclerosis. More precisely, the invention relates to inactivated protein derivatives of the hIFN-ϝ with preserved affinity to the hIFN-ϝ receptor. The derivatives represent genetically modified variants of hIFN-ϝ where the C-terminal part of the molecule is either deleted or replaced with a polypeptide sequence of another human protein and a recombinant hIFN-ϝ inactivated by physical or chemical methods.
    Type: Application
    Filed: October 5, 2005
    Publication date: August 20, 2009
    Inventors: Ivan Ivanov, Rumen Tsanev, Genoveva Nacheva, Hans-Guenther Grigoleit, Rolf Gunther
  • Publication number: 20060155305
    Abstract: In an extraction device (1) for extracting objects (2), in particular clots, foreign bodies, etc., from cavities (3) in a human or animal body, with first and second compressible and expandable collecting baskets (10, 20, 102, 110) between which the object (2) can be captured, said collecting baskets being mutually displaceable and being able to be drawn one into the other, at least one collecting basket (10) is umbrella-like in the expanded state and is designed with flexible wire-like adjustment elements for deliberately changing the shape and/or position of the collecting basket so that the object can be captured in the latter and can be drawn into the other collecting basket (20).
    Type: Application
    Filed: September 11, 2003
    Publication date: July 13, 2006
    Inventors: Franz Freudenthal, Rolf Gunther, Thomas Schmitz-Rode
  • Publication number: 20050267514
    Abstract: The present invention provides a removable vena cava filter for capturing thrombi in a blood vessel. The filter comprises a plurality of primary struts having first ends attached together along a longitudinal axis. Each primary strut includes an arcuate segment having a first tensile strength. The arcuate segment extends from the first end to an anchoring hook. The anchoring hook is integral with the arcuate segment and having the first thickness and first tensile strength. The filter further comprises a plurality of secondary struts freely spaced between the primary struts and having connected ends attached together along the longitudinal axis. Each secondary strut freely extends from the connected end to a free end avoiding contact with other secondary struts and primary struts. Each secondary strut has a second tensile strength.
    Type: Application
    Filed: April 18, 2005
    Publication date: December 1, 2005
    Inventors: Thomas Osborne, Arne Molgaard-Nielsen, Per Hendriksen, Rolf Gunther
  • Publication number: 20050267513
    Abstract: A removable filter having a collapsed state and an expanded state for capturing thrombi in a blood vessel is disclosed. The filter comprises a plurality of primary struts and a plurality of secondary struts. Each primary strut in the expanded state extends from a primary strut first end to an anchoring hook. Each primary strut extends arcuately along a longitudinal axis and linearly radially. The plurality of primary strut first ends are attached together along the longitudinal axis. Each secondary strut in the expanded state extends from a secondary strut first end to a free end. Each secondary strut extends arcuately along the longitudinal axis and linearly radially. The plurality of secondary struts are attached together along the longitudinal axis. The plurality of secondary struts centralize the filter in the expanded state in the blood vessel.
    Type: Application
    Filed: April 18, 2005
    Publication date: December 1, 2005
    Inventors: Thomas Osborne, Arne Molgaard-Nielsen, Per Hendriksen, Rolf Gunther
  • Publication number: 20050267512
    Abstract: The present invention provides a removable vena cava filter for capturing thrombi in a blood vessel. The filter comprises a plurality of primary struts having first ends attached together along a longitudinal axis. Each primary strut has an arcuate segment extending from the first end to an anchoring hook. The primary struts are configured to move between an expanded state for engaging the anchoring hooks with the blood vessel and a collapsed state for filter retrieval or delivery. Each primary strut are configured to cross another primary strut along the longitudinal axis in the collapsed state such that the arcuate segments occupy a first diameter greater than a second diameter occupied by the anchoring hooks in the collapsed state for filter retrieval or delivery.
    Type: Application
    Filed: April 18, 2005
    Publication date: December 1, 2005
    Inventors: Thomas Osborne, Arne Molgaard-Nielsen, Per Hendriksen, Rolf Gunther
  • Patent number: 6821755
    Abstract: The invention relates to advantageous processes for preparing heterologous proteins in prokaryotic host cells by improved codon use and/or expression of tRNAs which code for codons occurring rarely in said host cell.
    Type: Grant
    Filed: July 27, 2001
    Date of Patent: November 23, 2004
    Assignee: Boehringer Ingelheim International GmbH
    Inventors: Rolf-Günther Werner, Klaus Bergemann, Friedrich Götz, Andreas Peschel
  • Patent number: 6651616
    Abstract: In a method for the operation of a four-stroke reciprocating piston internal combustion engine with alternating compression. ignition and spark ignition, fuel is injected directly, fresh charge is delivered and combustion exhaust gas is led off. At low and medium partial load a partially homogenized, lean basic mixture of air, fuel and retained exhaust gas is formed for the compression ignition, and at higher partial load and at full load a homogeneous, stoichiometric mixture is formed for the spark ignition. Further features include exhaust gas retention, a build-up of exhaust gas and activation injection into the retained exhaust gas. For a smooth transition between the two operating modes, in addition to the co-ordinated interaction of exhaust gas retention, build up of exhaust gas, restriction of the fresh charge, and of the ignition advance angle in spark ignition, together with the quantity and the timing of the fuel injection, use is also made of exhaust gas recirculation.
    Type: Grant
    Filed: February 15, 2002
    Date of Patent: November 25, 2003
    Assignee: DaimlerChrysler AG
    Inventors: Andreas Juretzka, Rolf-Günther Nieberding
  • Publication number: 20030017531
    Abstract: The invention relates to advantageous processes for preparing heterologous proteins in prokaryotic host cells by improved codon use and/or expression of tRNAs which code for codons occurring rarely in said host cell.
    Type: Application
    Filed: July 27, 2001
    Publication date: January 23, 2003
    Inventors: Rolf-Gunther Werner, Klaus Bergemann, Friedrich Gotz, Andreas Peschel